# Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)

> **NCT00042029** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 324 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** MK0869, aprepitant
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00042029
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06-18
- **Primary completion:** 2003-10-03
- **Final completion:** 2003-10-03
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042029, "Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00042029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*